×
0 0 0 0 0 0 0 0
Stockreport

BRIEF-?Lexicon announces EMA acceptance of MAA for Sotagliflozin to treat adults with Type 1 Diabetes [Reuters]

Lexicon Pharmaceuticals, Inc (LXRX)  More Company Research Source: Reuters
Last lexicon pharmaceuticals, inc earnings: 11/1 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: lexpharma.com/investors
PDF BRIEF-?Lexicon announces EMA acceptance of MAA for Sotagliflozin to treat adults with Type 1 Diabetes? | Reuters Reuters Staff 1 Min Read March 29 (Reuters) - Lexicon Pharmaceuticals Inc: * ?LEXICON PHARMACEUTICALS ANNOUNCES EMA ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION (MAA) FOR SOTAGLIFLOZIN TO TREAT ADULTS WITH TYPE 1 DIABETES? Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2018 Reuters. All Rights Reserved. [Read more]

IMPACT SNAPSHOT EVENT TIME: LXRX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
LXRX alerts
from News Quantified
Opt-in for
LXRX alerts

from News Quantified
Opt-in for
LXRX alerts

from News Quantified